Clinical trial
Evaluation of Urinary Isoprostanes in the Assessment of Children With…
NCT00215020 · Boston Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00215020 |
|---|---|
| Title | Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease |
| Official title | Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease |
| Lead sponsor | Boston Children's Hospital, Other |
| Collaborators | Crohn's and Colitis Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Inflammatory Bowel Disease, Ulcerative Colitis, Crohn's Disease |
| Enrollment | 150 |
| Start date | Sep 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 27, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: